Glycopyrrolate Oral Solution — Class II drug recall D-0741-2026
Ongoing recall by Precision Dose Inc., reported 2026-07-29, distributed nationwide. Failed Impurities/Degradation Specifications
| Recall number | D-0741-2026 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | Precision Dose Inc., South Beloit, IL, United States |
| Recall initiated | 2026-07-14 |
| Classified | 2026-08-05 |
| Reported by FDA | 2026-07-29 |
| Distributed | Nationwide (US) |
| Reason classes | specification failure |
| NDC | 68094-0073, 68094-0073-01, 68094-0073-58 |
| Lot numbers | 506033 |
| Expiration dates | 2026-11-30 |
Product
Glycopyrrolate Oral Solution, 1 mg/5 mL, delivers 5 mL, Rx only, Pkg: Precision Dose, Inc, S. Beloil, IL 61080, unit-dose oral syringes, NDCs 68094-073-01 (oral syringe) and 68094-073-58 (case).
Reason for recall
Failed Impurities/Degradation Specifications
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0741-2026. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.